Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder (NCT07488156) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
United States34 participantsStarted 2026-03-01
Plain-language summary
The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder
This interventional study is aimed at:
* assessing and improving the health literacy and
* assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders
* Patients must be proficient in English.
* Patients must have a government issued social security number (required for reimbursement through the university).
Exclusion Criteria:
* Patients at UMCNO that are ages 17 or younger
* Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions
* Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications
* Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization
* Patients that are not proficient in English
* Patients that do not have a government issued social security number
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Post-intervention KAST (Knowledge About Schizophrenia Test) scores
Timeframe: This will be collected on Day 5 of the study, after the participant has completed both educational sessions.
2
Post-intervention ATT (Attitudes Toward Treatment) scores
Timeframe: This will be collected on Day 5 of the study, after the participant has completed both educational sessions.
Trial details
NCT IDNCT07488156
SponsorLouisiana State University Health Sciences Center in New Orleans